Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Bernice Kuca Net Worth & Insider Trades

Bernice Kuca - HeadClin. and Reg. Operations, Colucid Pharmaceuticals, Inc

As of March 1, 2017

What is Bernice Kuca's Net Worth?

The current estimated net worth of Colucid Pharmaceuticals, Inc's HeadClin. and Reg. Operations, Bernice Kuca, is estimated to be about $1.51M . Bernice Kuca owns about 40,086 units of Colucid Pharmaceuticals, Inc common stock. In the last 2 years at Colucid Pharmaceuticals, Inc, Bernice Kuca has sold an estimated value of $1.93M worth.

What is Bernice Kuca's Past Insider Trading?

Bernice Kuca's largest sale order was 772 units , worth over $27.98K on January 4, 2017. In total, Bernice Kuca has made about 5 transactions over 2 years of their time at Colucid Pharmaceuticals, Inc. Bernice Kuca usually trades in March, with the busiest year in 2017 and 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Bernice Kuca

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Bernice Kuca's' Mailing Address?

  • Mailing address is 15 New England Executive Park Burlington MA 01803 MA

What are Colucid Pharmaceuticals, Inc's Past Insider Trades?

Colucid Pharmaceuticals, Inc's most recent insider trade came on January 5, 2017 by Thomas P Mathers who sold 1,502 units worth $52.24K . In the last 2 years, insiders at Colucid Pharmaceuticals, Inc have sold an estimated value of $185.13M and bought an estimated value of $917.41M worth of shares. Insider trading is most common in May, with the busiest year in 2016. The most active traders at the company are Thomas P Mathers, Chief Executive Officer,  Raymond Skwierczynski, HeadPharmaceutical Operations,  and Linda C Hogan, Head .

CoLucid Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...